Phase 3Data readout

IONIS-FB-LRx

IgA nephropathy

IONSIonis Pharmaceuticals

Expected catalystDecember 31, 2026Company guidance: Dec 31, 2026

Catalyst overview

Event details

Drug or asset: IONIS-FB-LRx
Development stage: Phase 3
Event type: Data readout
Indication: IgA nephropathy

Research summary

What is being tracked?

This catalyst tracks a Phase 3 data readout for IONIS-FB-LRx in IgA nephropathy. The expected timing is based on the latest available company guidance and may change.

Development notes

Partnered w/Roche, advanced to Ph3 stage. 01/11/26:- IMAGINATION Ph3 sefaxersen IgAN study results in 2026 among partnered readouts.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Open source

IONIS-FB-LRx

Event details

What is being tracked?

Development notes

Primary source

Related pipeline programs

IONIS-APOCIII-LRx (Olezarsen)

Bepirovirsen (IONIS-HBVRx)

Zilganersen (ION373)

ION582